30 closest matches · ranked by relevance
Female Patient Preference
Primary: Proportion of Female Respondents Having Their Preferences Based on Physician Gender for the OB/GYN Care — 667; 87; 261 Participants
Cardiac Rhythm Disorder · Bradycardia · Cardiac Pacemaker Artificial
Primary: Mean Rankings for Pacemaker Device Features — 2.3; 2.6; 2.2; 4.7 score on a scale
Rhinitis, Allergic, Perennial
Primary: Comparison of Mean Change From Baseline in Daily Reflective Total Nasal Symptom Score (rTNSS) Over Treatment Periods of Active Drug Nasal Sprays Versus Placebos — -2.7…
Rhinitis, Allergic, Perennial
Primary: Comparison of Mean Change From Baseline in Daily Reflective Total Nasal Symptom Score (rTNSS) Over Each Treatment Period of Active Drug Nasal Sprays Versus Placebos…
Prostate Cancer
Primary: Change in Satisfaction With Care — 0.26; 0.07; 0.28; 0.06 units on a scale
Gynecology · Surgery · Opioid Use
Primary: # of Opioid Pills Consumed — 26.7; 38.4 % oxycodone used
Satisfaction · Postoperative Complications · Pelvic Floor Disorder
Primary: Patient Satisfaction — 43; 42; 43; 45 participants
Postoperative Pain
Primary: Opioid Consumption in the 0-48 Hour Study Periods. — 10; 5; 10; 5 milligram morphine equivalents (MMEQ)
Patient Satisfaction
Primary: Effect of Surgical Lights on Patient Preference — 37.7; 46.8; 0.00; 1.3 percentage of participants
Contraception
Primary: Number of Participants Choosing Each Hormonal Contraceptive Method Before and After Counseling — 1207; 1199; 60; 131 Participants — p=0.705
Obstructive Sleep Apnea
Primary: Apnoea Hypopnoea Index (AHI) — 0.96; 0.91 events/hour
Pelvic Organ Prolapse · Stress Urinary Incontinence · Overactive Bladder
Primary: Patient Knowledge — 60; 72 percentage of questions answered correct — p=0.06
Sexually Transmitted Diseases
Primary: Number of Patients Recording Preferences to Restrict Provider Access to Some or All Electronic Health Record (EHR) Data — 45; 13 participants
Breast Cancer
Primary: Percentage of Acceptable Overall Image Quality — 30; 33; 3; 0 Participants
Diabetes Mellitus, Type 2
Primary: Patient Overall Preference — 4.75; 2.45 units on a scale — p=<0.0001
Type II Diabetes
Primary: Patient Medication Preference as Estimated by a Choice Model — 0.983; 0.362; 0.284; 0.261 utility of
Alcohol and Substance-Related Mental Disorders · Sexually Transmitted Diseases
Primary: Feasibility of Providing Intervention — 25; 22 Participants
Pulmonary Disease, Chronic Obstructive
Primary: Total Mean Score of the Validated Patient Satisfaction and Preference Questionnaire (PASAPQ) — 80.71; 79.92 units on a scale
Bladder Dysfunction · Urinary Retention
Primary: Total Catheter Related Pain — 1.25; 2.3 units on a scale
Contraception
Primary: Number of Participants With Depot Medroxyprogesterone Acetate (DMPA sc) Continuation at One Year by Self-report in Both the Self- and Clinic Administration Arms — 108…
Hematuria · Urination Disorders · Voiding Dysfunction
Primary: Visual Analog Scale for Pain — 1.8; 1.4 Units on a Scale — p=.39
Breast Cancer · Colorectal Cancer · Kidney Cancer
Primary: Priorities of Patients Receiving First Medical Treatment for Cancer at Treatment Initiation — 199; 93; 141; 80 Participants
Anxiety
Primary: State-Trait Anxiety Inventory-State Scores — 37.9; 40.7; NA; 37.7 units on a scale
Pelvic Floor Disorders
Primary: Patient Reported Ease of Dilation — 6.6; 7.4; 8.0 units on a scale
Surgical Preparation of the Vagina
Primary: Number of Participants With Vaginal or Urinary Symptoms After Surgery, Assessed by Validated Questionnaire (Modified PRO-CTCAE) — 4; 11; 8; 25 Participants
Intravaginal Ring Use
Primary: USPE Scale Scores — 3.73; 3.63; 1.85; 2.02 score on a scale
Rheumatoid Arthritis · Plaque Psoriasis
Primary: Percentage of Participants With a Preference for Autoinjector A Versus Autoinjector B — 41.7; 43.5; 36.8 percentage of participants
Hematologic Neoplasms
Primary: Content Validity of Best-Worst Scaling (BWS) Survey — 10; 0 Participants
Rheumatic Diseases · Physician-Patient Relations · Contraception
Primary: Acceptability of Intervention — 4.45; 3.97 score on a scale
Safety · Acceptability
Primary: Number of Participants That Successfully Insert Vaginal Film — 8; 8; 22; 22 Participants — p=>.99